FLT3 and acute myeloid leukemia: Genetic abnormalities are detected in 50-60% of the patients with acute myeloid leukemia by conventional cytogenetic and FISH method.2 Cytogenetic abnormalities alone are not sufficient for AML formation, mutations such as FLT3 and RAS must be acquired additionally.